Cargando…

Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis

In trauma patients, bleeding can lead to coagulopathy, hemorrhagic shock, and multiorgan failure, and therefore is of fundamental significance in regard to early morbidity. We conducted a meta-analysis to evaluate the efficacy and safety of tranexamic acid (TXA) in civil and military settings and it...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Jeabory, Mahdi, Szarpak, Lukasz, Attila, Kecskes, Simpson, Michael, Smereka, Adam, Gasecka, Aleksandra, Wieczorek, Wojciech, Pruc, Michal, Koselak, Maciej, Gawel, Wladyslaw, Checinski, Igor, Jaguszewski, Milosz J., Filipiak, Krzysztof J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958951/
https://www.ncbi.nlm.nih.gov/pubmed/33802254
http://dx.doi.org/10.3390/jcm10051030
_version_ 1783664891549188096
author Al-Jeabory, Mahdi
Szarpak, Lukasz
Attila, Kecskes
Simpson, Michael
Smereka, Adam
Gasecka, Aleksandra
Wieczorek, Wojciech
Pruc, Michal
Koselak, Maciej
Gawel, Wladyslaw
Checinski, Igor
Jaguszewski, Milosz J.
Filipiak, Krzysztof J.
author_facet Al-Jeabory, Mahdi
Szarpak, Lukasz
Attila, Kecskes
Simpson, Michael
Smereka, Adam
Gasecka, Aleksandra
Wieczorek, Wojciech
Pruc, Michal
Koselak, Maciej
Gawel, Wladyslaw
Checinski, Igor
Jaguszewski, Milosz J.
Filipiak, Krzysztof J.
author_sort Al-Jeabory, Mahdi
collection PubMed
description In trauma patients, bleeding can lead to coagulopathy, hemorrhagic shock, and multiorgan failure, and therefore is of fundamental significance in regard to early morbidity. We conducted a meta-analysis to evaluate the efficacy and safety of tranexamic acid (TXA) in civil and military settings and its impact on in-hospital mortality (survival to hospital discharge or 30-day survival), intensive care unit and hospital length of stay, incidence of adverse events (myocardial infarct and neurological complications), and volume of blood product transfusion. The systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic review of the literature using PubMed, Scopus, EMBASE, Web of Science, and the Cochrane Central Register and Controlled Trials (CENTRAL) database was conducted from inception to 10 January 2021. In-hospital mortality was reported in 14 studies and was 15.5% for the TXA group as compared with 16.4% for the non-TXA group (OR = 0.81, 95% CI 0.62–1.06, I(2) = 83%, p = 0.12). In a civilian TXA application, in-hospital mortality in the TXA and non-TXA groups amounted to 15.0% and 17.1%, respectively (OR = 0.69, 95% CI 0.51–0.93, p = 0.02, I(2) = 78%). A subgroup analysis of the randomized control trial (RCT) studies showed a statistically significant reduction in in-hospital mortality in the TXA group (14.3%) as compared with the non-TXA group (15.7%, OR = 0.89, 95% CI 0.83–0.96, p = 0.003, I(2) = 0%). To summarize, TXA used in civilian application reduces in-hospital mortality. Application of TXA is beneficial for severely injured patients who undergoing shock and require massive blood transfusions. Patients who undergo treatment with TXA should be monitored for clinical signs of thromboembolism, since TXA is a standalone risk factor of a thromboembolic event and the D-dimers in traumatic patients are almost always elevated.
format Online
Article
Text
id pubmed-7958951
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79589512021-03-16 Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis Al-Jeabory, Mahdi Szarpak, Lukasz Attila, Kecskes Simpson, Michael Smereka, Adam Gasecka, Aleksandra Wieczorek, Wojciech Pruc, Michal Koselak, Maciej Gawel, Wladyslaw Checinski, Igor Jaguszewski, Milosz J. Filipiak, Krzysztof J. J Clin Med Article In trauma patients, bleeding can lead to coagulopathy, hemorrhagic shock, and multiorgan failure, and therefore is of fundamental significance in regard to early morbidity. We conducted a meta-analysis to evaluate the efficacy and safety of tranexamic acid (TXA) in civil and military settings and its impact on in-hospital mortality (survival to hospital discharge or 30-day survival), intensive care unit and hospital length of stay, incidence of adverse events (myocardial infarct and neurological complications), and volume of blood product transfusion. The systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic review of the literature using PubMed, Scopus, EMBASE, Web of Science, and the Cochrane Central Register and Controlled Trials (CENTRAL) database was conducted from inception to 10 January 2021. In-hospital mortality was reported in 14 studies and was 15.5% for the TXA group as compared with 16.4% for the non-TXA group (OR = 0.81, 95% CI 0.62–1.06, I(2) = 83%, p = 0.12). In a civilian TXA application, in-hospital mortality in the TXA and non-TXA groups amounted to 15.0% and 17.1%, respectively (OR = 0.69, 95% CI 0.51–0.93, p = 0.02, I(2) = 78%). A subgroup analysis of the randomized control trial (RCT) studies showed a statistically significant reduction in in-hospital mortality in the TXA group (14.3%) as compared with the non-TXA group (15.7%, OR = 0.89, 95% CI 0.83–0.96, p = 0.003, I(2) = 0%). To summarize, TXA used in civilian application reduces in-hospital mortality. Application of TXA is beneficial for severely injured patients who undergoing shock and require massive blood transfusions. Patients who undergo treatment with TXA should be monitored for clinical signs of thromboembolism, since TXA is a standalone risk factor of a thromboembolic event and the D-dimers in traumatic patients are almost always elevated. MDPI 2021-03-03 /pmc/articles/PMC7958951/ /pubmed/33802254 http://dx.doi.org/10.3390/jcm10051030 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Al-Jeabory, Mahdi
Szarpak, Lukasz
Attila, Kecskes
Simpson, Michael
Smereka, Adam
Gasecka, Aleksandra
Wieczorek, Wojciech
Pruc, Michal
Koselak, Maciej
Gawel, Wladyslaw
Checinski, Igor
Jaguszewski, Milosz J.
Filipiak, Krzysztof J.
Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis
title Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis
title_full Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis
title_fullStr Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis
title_full_unstemmed Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis
title_short Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis
title_sort efficacy and safety of tranexamic acid in emergency trauma: a systematic review and meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958951/
https://www.ncbi.nlm.nih.gov/pubmed/33802254
http://dx.doi.org/10.3390/jcm10051030
work_keys_str_mv AT aljeaborymahdi efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT szarpaklukasz efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT attilakecskes efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT simpsonmichael efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT smerekaadam efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT gaseckaaleksandra efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT wieczorekwojciech efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT prucmichal efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT koselakmaciej efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT gawelwladyslaw efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT checinskiigor efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT jaguszewskimiloszj efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis
AT filipiakkrzysztofj efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis